Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) missed Wall Street’s revenue expectations in Q4 CY2024 as sales rose 4.7% year on year to $186.5 million. Its non-GAAP profit of $0.92 per share was 1.9% below analysts’ consensus estimates.
Clover Health (NASDAQ:CLOV) Reports Sales Below Analyst Estimates In Q4 Earnings
Health insurance company Clover Health (NASDAQ:CLOV) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 34% year on year to $337 million. Its GAAP loss of $0.04 per share was $0.03 above analysts’ consensus estimates.
iHeartMedia (NASDAQ:IHRT) Misses Q4 Revenue Estimates, Stock Drops
Global media and entertainment company iHeartMedia (NASDAQ:IHRT) missed Wall Street’s revenue expectations in Q4 CY2024 as sales rose 4.8% year on year to $1.12 billion. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $1.10 billion at the midpoint, or 33.7% above analysts’ estimates.
Astrana Health’s (NASDAQ:ASTH) Q4 Sales Beat Estimates
Healthcare services company Astrana Health announced better-than-expected revenue in Q4 CY2024, with sales up 88.4% year on year to $665.2 million. The company expects the full year’s revenue to be around $2.6 billion, close to analysts’ estimates. Its GAAP loss of $0.15 per share was significantly below analysts’ consensus estimates.
Monster (NASDAQ:MNST) Posts Q4 Sales In Line With Estimates
Energy drink company Monster Beverage (NASDAQ:MNST) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.7% year on year to $1.81 billion. Its non-GAAP profit of $0.38 per share was 5.5% below analysts’ consensus estimates.
Here's How Mainland China May Allow Chinese Traders Access to Bitcoin
Beijing isn't going to allow crypto exchanges to directly operate BTC in China, but there might be a way that Hong Kong crypto ETFs can be traded in the mainland.
Natera (NASDAQ:NTRA) Reports Bullish Q4, Guides for Strong Full-Year Sales
Genetic testing company Natera (NASDAQ:NTRA). reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 53% year on year to $476.1 million. The company’s full-year revenue guidance of $1.91 billion at the midpoint came in 5.8% above analysts’ estimates. Its GAAP loss of $0.41 per share was 9.3% below analysts’ consensus estimates.
Traders Flee Risk, Seek Havens to Hedge Uncertain Stock Market
(Bloomberg) -- For two years, Wall Street traders have minted profits simply by chasing the hottest stocks in the market regardless of price, fundamentals or the economic backdrop. Those days appear to be over.Most Read from BloombergCuts to Section 8 Housing Assistance Loom Amid HUD UncertaintyThe Trump Administration Takes Aim at Transportation ResearchShelters Await Billions in Federal Money for Homelessness ProvidersNYC’s Congestion Pricing Pulls In $48.6 Million in First MonthNew York’s Con
SoundHound AI’s (NASDAQ:SOUN) Q4 Sales Beat Estimates, Stock Jumps 11.5%
Voice AI recognition company SoundHound (NASDAQ:SOUN) announced better-than-expected revenue in Q4 CY2024, with sales up 101% year on year to $34.54 million. Its GAAP loss of $0.69 per share was significantly below analysts’ consensus estimates.
Jamf’s (NASDAQ:JAMF) Q4 Earnings Results: Revenue In Line With Expectations But Full-Year Sales Guidance Misses Expectations Significantly
Apple device management company, Jamf (NASDAQ:JAMF) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 8.2% year on year to $163 million. On the other hand, next quarter’s revenue guidance of $166.5 million was less impressive, coming in 0.7% below analysts’ estimates. Its non-GAAP profit of $0.17 per share was 11% above analysts’ consensus estimates.